Fractional-Dose Vaccination Offers Long-Lasting Protection Against Yellow Fever
A one-fifth dose of yellow fever vaccine protects against yellow fever for 10 years and does not require a booster. Findings from a follow-up study of a randomized controlled, non-inferiority trial are published in Annals of Internal Medicine.
Yellow fever is an acute viral hemorrhagic disease that is spread by infected mosquitoes. In a recent outbreak of urban yellow fever in Angola and the Democratic Republic of Congo, 4,347 suspected cases and 377 deaths were reported from December 2015 to October 2016. Since there is no cure, vector control and vaccination are essential for prevention. Outbreaks of yellow fever and a frequently depleted vaccine stock increase demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus (17D-YFV) vaccine has been shown to be non-inferior to the standard dose for inducing a protective immune response, but whether this dose provides long-term protection is not known.
Researchers from Leiden University Medical Center, Leiden, the Netherlands, studied 10 year follow-up data on a subgroup of patients from the trial to evaluate whether fractional-dose vaccination conferred long-term immunity. They found that 97 percent of participants had protective levels of yellow-fever neutralizing antibodies more than 10 years after receiving fractional dose of 17D-YFV vaccine compared with 34 of 35 who received the standard dose. According to the researchers, this is one of the first studies to document long-term protection after fractional-dose yellow fever vaccination. These findings reinforce the policy of using fractional doses in preventive mass vaccination campaigns before an impeding outbreak and also show that a booster dose is not necessary.
Source: American College of Physicians
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
